Bernstein initiated coverage on six pharma stocks, expressing a positive outlook on the Indian healthcare sector driven by AI, innovation in niche areas, and a strengthening ecosystem. The brokerage highlighted attractive valuations and easing policy uncertainties, naming Zydus Lifesciences as its top pick with a significant upside potential.